Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery
Public ClinicalTrials.gov record NCT00130715. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Multicenter, Controlled Evaluation of the Efficacy and Safety of Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the efficacy of Seprafilm in reducing the incidence of bowel obstruction and to evaluate the incidence of all serious adverse events (SAEs) associated with the use of Seprafilm occurring within 30 days postoperatively, and the incidence of abdominopelvic abscess within 6 months postoperatively.
Study identification
- NCT ID
- NCT00130715
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- Not listed
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 1998 (Type not available)
- Primary completion
- Not listed
- Completion
- Aug 2003 (Type not available)
- Last update posted
- Mar 12, 2015
1998 – 2003
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic | Scottsdale | Arizona | — | — |
| Kaiser Permanente Medical Center | Los Angeles | California | — | — |
| USC School of Medicine | Los Angeles | California | — | — |
| Harbor UCLA | Torrence | California | — | — |
| Washington Hospital Center | Washington D.C. | District of Columbia | — | — |
| Cleveland Clinic | Weston | Florida | — | — |
| Johns Hopkins Medical Center | Baltimore | Maryland | — | — |
| Boston Medical Center | Boston | Massachusetts | — | — |
| Brigham and Women's Hospital | Boston | Massachusetts | — | — |
| Mayo Medical Center | Rochester | Minnesota | — | — |
| Colon & Rectal Surgery Associates | Saint Paul | Minnesota | — | — |
| Washington University School of Medicine | St Louis | Missouri | — | — |
| Mount Sinai School of Medicine | New York | New York | — | — |
| Duke University Medical Center | Durham | North Carolina | — | — |
| Cleveland Clinic | Cleveland | Ohio | — | — |
| University of Texas Medical School | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00130715, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 12, 2015 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00130715 live on ClinicalTrials.gov.